Phospho-Bad (Ser112) Antibody [F3L12]

Catalog No.: F3347

    Application: Reactivity:
    • Lane 1: HeLa, Lane 2: HeLa (Calyculin A, 100 ng/ml, 30 min )
    1/

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    転写条件(ウェット): 200 mA, 60 min,Recommended to use 0.22 μm PVDF 膜の使用をお勧めします。

    使用情報

    Dilution
    1:5000
    1:30
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Rat, Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    18 kDa 23 kDa
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール HeLa cells (Calyculin A, 100 ng/ml, 30 min); C6 cells (Calcyculin A treated)
    ネガティブコントロール C6 cells; HeLa cells

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.22 µm PVDF membrane is recommended )Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 60 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:5000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    Phospho-Bad (Ser112) Antibody [F3L12] detects endogenous levels of total Bad protein only when it is phosphorylated at Ser112.
    タンパク質の局在
    細胞質、細胞内膜系、ミトコンドリア、ミトコンドリア外膜
    Uniprot ID
    Q92934
    Clone
    F3L12
    Synonym(s)
    BBC6; BCL2L8; BAD; Bcl2-associated agonist of cell death; Bcl-2-binding component 6; Bcl-2-like protein 8; Bcl-xL/Bcl-2-associated death promoter; Bcl2 antagonist of cell death; Bcl2-L-8
    Background
    Phospho-Bad Ser112 refers to the serine 112 phosphorylation site on Bad, a 184-amino acid proapoptotic BH3-only member of the Bcl-2 family that forms heterodimers with anti-apoptotic Bcl-2 and Bcl-xL through its alpha-helical BH3 domain spanning residues 103 to 127, with key residues Leu107, Asp112, and Leu118 crucial for insertion into the Bcl-xL binding groove and displacement of Bax or Bak to trigger mitochondrial outer membrane permeabilization and apoptosis. Ser112 is located N-terminal to the BH3 amphipathic helix in a flexible loop, and phosphorylation at this site induces conformational changes that expose 14-3-3 phospho-binding motifs, specifically the mode I RSXpSXP motif at residues 112 to 117 and, when Ser136 is also phosphorylated, the mode II RXYpSXP motif at residues 136 to 141. This modification disrupts the amphipathic nature of the BH3 helix and inhibits docking to Bcl-xL, instead promoting cytosolic sequestration of Bad by 14-3-3 proteins. Ser112 phosphorylation mediates survival signaling in response to growth factors such as IL-3 or EGF, which activate the Ras/Raf to MAPK/ERK to p90RSK pathway or mitochondria-anchored PKA, leading to Bad phosphorylation and sequestration in 14-3-3 complexes, thereby blocking its pro-apoptotic activity and supporting cell survival and proliferation. Dephosphorylation by PP2A, particularly upon withdrawal of survival signals, destabilizes 14-3-3 binding and, together with loss of phosphorylation at Ser136 (by Akt) and Ser155 (by PKA), releases Bad to antagonize Bcl-xL or Bcl-2 and promote apoptosis. This regulatory mechanism links cytokine and PI3K-independent MAPK pathways to the mitochondrial apoptosis rheostat and is especially important for lymphocyte and growth factor-dependent cell survival. Hyperphosphorylated Bad mediated by oncogenic Ras or MAPK pathways contributes to therapy resistance in cancers such as leukemia and carcinomas, while reactivation of PP2A can resensitize tumors to apoptosis.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください